Fig. 6From: Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanomaEvaluation of the MLDIS model. The performance of MLDIS was compared with other clinical and molecular variables in predicting prognosis in GSE22153 (A), GSE54467 (B), TCGA-SKCM (C), and GSE59455 (D). C-index analysis MLDIS and 51 published signatures in GSE22153 (E), GSE54467 (F), TCGA-SKCM (G), and GSE59455 (H)Back to article page